医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Asia Invests in Biotechnology Innovations to Boost Food Safety, Sustainability

2021年01月19日 AM10:42
このエントリーをはてなブックマークに追加


 

BEIJING

Asia is actively investing in biotechnology innovations to meet the needs of its rapidly growing population.

Calysseo’s FeedKind® single-cell protein project is one such biotechnology innovation that will enhance regional food safety and sustainability.

FeedKind® is an alternative bio-protein feed ingredient for the aquaculture industry. It is made by fermenting natural gas to create a safe, nutritious, traceable and affordable protein.

Calysseo has appointed the consortium of Black & Veatch and Shanghai LBT Engineering & Technology Co. Ltd to execute the full Engineering, Procurement and Construction (EPC) scope for its first commercial FeedKind® production facility.

Calysseo is a joint venture established by alternative protein producer Calysta and animal nutrition company Adisseo.

“Food security remains a priority in regions with growing populations like Asia. Alternative proteins, like FeedKind®, will contribute to building a more sustainable and resilient food system. We are excited to draw on our extensive experience in processing, handling and treating natural gas and our deep consulting, engineering and construction expertise to deliver the project execution certainty required by biotechnology leaders, like Calysseo,” said Jim Schnieders, Executive Vice President and Managing Director Floating Oil & Gas Solutions and Emerging Markets, Oil & Gas, Black & Veatch.

“Through strong and seamless cooperation with Black & Veatch, we will provide the best local content with design, fabrication and construction services for the first commercial project of Calysseo in China. This consortium teaming also provides a new EPC execution model that extends LBT’s full engineering value chain to global customers,” said Binqiang Shen, Chairman of Shanghai LBT Engineering & Technology Co. Ltd.

Located in Chongqing in southwest China, the biotechnology facility is projected to produce 20,000 tons per annum of FeedKind® by 2022.

As the consortium leader, Black & Veatch will provide project management, process design and global procurement expertise. Shanghai LBT Engineering and Technology Co. Ltd will provide local engineering design, permitting and construction expertise.

Black & Veatch provides innovative and cost-effective solutions on Liquefied Natural Gas (LNG), Floating LNG (FLNG), sulfur recovery, gas processing, gasification, and ammonia/fertilizer projects. It supports industries like biotechnology and food processing with a full range of services and engineering from consulting to design; to full engineering, procurement, construction (EPC) and start-up for projects.

Editor’s Notes:

  • Biotechnology is the use of living systems and organisms to develop products.
  • The United Nations (UN) estimates that Asia’s current population of 4.6 billion is equivalent to almost 60 percent of the total world population. The UN forecasts that by 2050, Asia will have a population of 5.2 billion.
  • In 2019, Black & Veatch was awarded the Front-End Engineering Design (FEED) for the FeedKind® aquafeed project by Calysseo. After the FEED was completed, Black & Veatch developed an execution strategy for a full-scope EPC solution.
  • In 2017, Black & Veatch supported the joint venture of Calysta and Cargill on a similar biotechnology project planned for Memphis, Tennessee, United States.

About Black & Veatch

Black & Veatch is an employee-owned engineering, procurement, consulting and construction company with a more than 100-year track record of innovation in sustainable infrastructure. Since 1915, we have helped our clients improve the lives of people in over 100 countries by addressing the resilience and reliability of our world’s most important infrastructure assets. Our revenues in 2019 were US$3.7 billion. Follow us on www.bv.com and on social media.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210118005558/en/

CONTACT

Black & Veatch

EMILY CHIA | +65 6761 3511 p | +65 9875 8907 m | ChiaLP@BV.com

24-HOUR MEDIA HOTLINE | +1 866 496 9149

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 美国政商领袖签署致拜登总统公开信,呼吁美国展现领导力以加速全球疫苗接种工作
  • Ferring和Rebiotix将在2021消化疾病周大会上公布基于微生物群的在研活体生物治疗药物RBX2660的里程碑数据
  • アスターDMヘルスケア、25万米ドル相当の世界看護賞を発表
  • Prestige BioPharma Enters MOU with Busan City for Establishment of its R&D Centre in Busan, South Korea
  • Celltrion Confirms Neutralising Potency Against Emerging SARS-CoV-2 Variants With Anti-COVID-19 Monoclonal Antibody Treatment regdanvimab (CT-P59)